Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2008, Vol. 9 Issue (2): 85-89    DOI: 10.1631/jzus.B0710617
Medical Genetics     
BRCA1/2 associated hereditary breast cancer
Li-song TENG, Yi ZHENG, Hao-hao WANG
Cancer Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Breast cancer is one of the leading causes of death in women today. Some of the patients are hereditary, with a large proportion characterized by mutation in BRCA1 and/or BRCA2 genes. In this review, we provide an overview of these two genes, focusing on their relationship with hereditary breast cancers. BRCA1/2 associated hereditary breast cancers have unique features that differ from the general breast cancers, including alterations in cellular molecules, pathological bases, biological behavior, and a different prevention strategy. But the outcome of BRCA1/2 associated hereditary breast cancers still remains controversial; further studies are needed to elucidate the nature of BRCA1/2 associated hereditary breast cancers.

Key wordsBRCA1      BRCA2      Hereditary breast cancer     
Received: 08 December 2007      Published: 06 January 2008
CLC:  R737.9  
Cite this article:

Li-song TENG, Yi ZHENG, Hao-hao WANG. BRCA1/2 associated hereditary breast cancer. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2008, 9(2): 85-89.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B0710617     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2008/V9/I2/85

[1] Lin-run Wang, Guo-bing Zhang, Jian Chen, Jun Li, Ming-wei Li, Nong Xu, Yang Wang, Jian-zhong Shentu. RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2011, 12(3): 174-179.